313 related articles for article (PubMed ID: 12450690)
1. Candidate peptide vaccine induced protection against classical swine fever virus.
Dong XN; Wei K; Liu ZQ; Chen YH
Vaccine; 2002 Dec; 21(3-4):167-73. PubMed ID: 12450690
[TBL] [Abstract][Full Text] [Related]
2. Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2.
Dong XN; Qi Y; Ying J; Chen X; Chen YH
Vaccine; 2006 Jan; 24(4):426-34. PubMed ID: 16154668
[TBL] [Abstract][Full Text] [Related]
3. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
[TBL] [Abstract][Full Text] [Related]
5. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.
de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
Vet Microbiol; 2001 Feb; 78(4):307-17. PubMed ID: 11182497
[TBL] [Abstract][Full Text] [Related]
6. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
[TBL] [Abstract][Full Text] [Related]
7. The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.
Li Y; Yuan M; Han Y; Xie L; Ma Y; Li S; Sun Y; Luo Y; Li W; Qiu HJ
J Virol; 2022 Jan; 96(2):e0176821. PubMed ID: 34730400
[TBL] [Abstract][Full Text] [Related]
8. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
[TBL] [Abstract][Full Text] [Related]
9. Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2.
Dong XN; Chen YH
Vaccine; 2006 Mar; 24(11):1906-13. PubMed ID: 16300867
[TBL] [Abstract][Full Text] [Related]
10. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
11. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
[TBL] [Abstract][Full Text] [Related]
12. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
Reimann I; Depner K; Trapp S; Beer M
Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
14. A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus.
Bohórquez JA; Defaus S; Muñoz-González S; Perez-Simó M; Rosell R; Fraile L; Sobrino F; Andreu D; Ganges L
Virus Res; 2017 Jun; 238():8-12. PubMed ID: 28571760
[TBL] [Abstract][Full Text] [Related]
15. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV.
Tong W; Zheng H; Li GX; Gao F; Shan TL; Zhou YJ; Yu H; Jiang YF; Yu LX; Li LW; Kong N; Tong GZ; Li JC
Antiviral Res; 2020 Jan; 173():104652. PubMed ID: 31751590
[TBL] [Abstract][Full Text] [Related]
16. Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response.
Zhou B; Liu K; Jiang Y; Wei JC; Chen PY
Virol J; 2011 Jul; 8():378. PubMed ID: 21801433
[TBL] [Abstract][Full Text] [Related]
17. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.
van Gennip HG; van Rijn PA; Widjojoatmodjo MN; de Smit AJ; Moormann RJ
Vaccine; 2000 Oct; 19(4-5):447-59. PubMed ID: 11027808
[TBL] [Abstract][Full Text] [Related]
18. P108 and T109 on E2 Glycoprotein Domain I Are Critical for the Adaptation of Classical Swine Fever Virus to Rabbits but Not for Virulence in Pigs.
Xie L; Han Y; Ma Y; Yuan M; Li W; Li LF; Li M; Sun Y; Luo Y; Li S; Hu S; Li Y; Qiu HJ
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581110
[TBL] [Abstract][Full Text] [Related]
19. Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China.
Luo Y; Ji S; Lei JL; Xiang GT; Liu Y; Gao Y; Meng XY; Zheng G; Zhang EY; Wang Y; Du ML; Li Y; Li S; He XJ; Sun Y; Qiu HJ
Vet Microbiol; 2017 Mar; 201():154-161. PubMed ID: 28284603
[TBL] [Abstract][Full Text] [Related]
20. A promising multiple-epitope recombinant vaccine against classical swine fever virus.
Tian H; Hou X; Wu J; Chen Y; Shang Y; Yin S; Zhang K; Liu X
Vet Immunol Immunopathol; 2014 Jan; 157(1-2):59-64. PubMed ID: 24269058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
